Categorized | Stock Profiles

MDEX (Madison Explorations, Inc.)

Share Button


mdex-logoMadison Exploration Inc. (MDEX) is the creator of a new, innovative cannabinoid product known as CannaStrips, a new smokeless cannabinoid therapy delivery technology.

CannaStrips is a new alternative form of medical cannabis developed by MDEX’s pharmaceutical professionals that utilize the highest grade of medical cannabis and pharmaceutical ingredients while still complying with federal regulations. Each CannaStrip is administered through the mouth for quick delivery of medical relief which contains a concentrated and controlled amount of cannabis that will deliver pain relief, increase appetite, sleeplessness, reduce anxiety, reduce nausea, and many other conditions.

Currently, MDEX is continuing its development of its product, product formulation and production method including proprietary equipment that will be leased to State approved cannabis production facilities and dispensaries. An initial focus will be geared on the states of Colorado, Washington, and California where the market is actively growing.


Symbol: MDEX  [ Current PPS: $0.1099  Outstanding Shares: 113M  Float: 48.8M  – a/o September 29, 2014 ]





  • The cannabinoid market is estimated to total $30-$50 billion however, based on the Federal Medical Cannabis Program internal estimates believe the market will actually be worth $74 billion in 2017.
  • Cannabinoids have been found to aid migraine headaches, insomnia, depression, epileptic seizures, chronic heartburn, AIDS/HIV, Alzheimers, Asthma, AutoimmuneDisease, Cancer, Crohn’s Disease, Diabetes, Digestive Disover, Gastro Intestinal (GERD), Glaucoma, High Blood Pressure, Influenza, Multiple Sclerosis, Pain Management, and Tourette Syndrome
  • The U.S House and Senate is currently aiming to change the medical cannabis laws
  • The New York Times recently released an article comparing the medical marijuana market as the new “repealing prohibition” era.
  • According to ArcView Market Research, the U.S Cannabis Industry increased 64% in 2013, is expected to total $2.34 billion by the end of 2014, and increase to $10.2 billion by 2019.
  • In April 2014, the Marijuana Business Daily predicted that U.S retail cannabis sales has the potential to total $7.4 – $8.2 billion by 2018.
  • In 2013, over $1.43 billion worth of legal marijuana was sold between medical cannabis retailers, processors, and dispensaries and is expected to increase 64% to $2.34 billion by 2014
  • Colorado shop owners estimate they generated over $1 million in collective sales on the first day of legalization.
  • The state of Colorado also expects tax revenue of marijuana sales to total $91 million.
  • Colorado estimates the industry could generate the state $600 million in revenues for 2014.
  • Sales in the state of Washington have exceeded $10 million however the supply is not meeting the demand.
  • A recent article by CNBC details “How legal marijuana could be the next great American industry.”

Recent News


Get Updates on MDEX and other Hot Penny Stocks by Signing Up to our Free E-mail Newsletter!

This post was written by:

- who has written 2169 posts on StockRockandRoll.

Contact the author

Comments are closed.

© 2020 MJ Capital, LLC | All rights reserved